PLx Pharma Winddown Corp.
PLXPQ
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -8.50M | -11.86M | -10.79M | 3.56M | -21.64M |
| Total Depreciation and Amortization | 58.00K | 49.00K | 56.00K | 55.20K | 73.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 300.00 | 0.00 |
| Total Other Non-Cash Items | -1.12M | -1.60M | -6.32M | -23.40M | 12.53M |
| Change in Net Operating Assets | -1.43M | -4.69M | 156.00K | 6.42M | 46.00K |
| Cash from Operations | -10.98M | -18.10M | -16.89M | -13.36M | -9.00M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 500.00 | 49.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 500.00 | 49.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | 1.09M | 1.33M | -- | 198.20K | 11.33M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.09M | 1.33M | -- | 198.20K | 11.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.90M | -16.77M | -16.89M | -13.16M | 2.38M |